Nebius Group (NBIS) said it has closed a private offering of convertible senior notes, raising around $4.3B in gross proceeds as the company looks to fund data center build-outs and expand its ...

Nebius (NBIS) stock secures $4.34B in convertible debt to fund AI data centers following $27B Meta deal and $2B Nvidia ...

Calgary, Alberta / October 15, 2025 –TheNewswire -Credissential Inc. (“Credissential” or the “Company”) (CSE: WHIP), a vertically integrated AI software development companyis pleased to announce a non ...

“We are extremely pleased with the outstanding response to the Convertible Note Offering from high quality institutional investors in the United States, which is a tremendous endorsement of Caledonia ...

Duke Energy (DUK) announced the pricing of $1.3 billion in convertible senior notes due in 2029 through a private placement. This amount is higher than the previously stated $1 billion. The initial ...

indie Semiconductor, Inc. (NASDAQ:INDI) is included in our list of the 11 most oversold semiconductor stocks to buy now. Positive analyst sentiment continues to surround indie Semiconductor, Inc.

CHICAGO--(BUSINESS WIRE)--JBT Marel Corporation (NYSE and Nasdaq Iceland: JBTM) announced today that it intends to offer $500 million aggregate principal amount of convertible senior notes due 2030 ...

(RTTNews) - Mesoblast Limited (MESO, MSB.AX) announced that it has entered into convertible note subscription agreements with SurgCenter principals and existing Mesoblast shareholders, Gregory George ...

TOKYO, Japan, July 18, 2025 (GLOBE NEWSWIRE) -- Linkage Global Inc (NASDAQ: LGCB) ("Linkage Global" or the "Company"), a cross-border e-commerce integrated services provider headquartered in Japan, ...

MIDLAND, Texas--(BUSINESS WIRE)--AST SpaceMobile, Inc. (“AST SpaceMobile”) (NASDAQ: ASTS), the company building the first and only space-based cellular broadband network accessible directly by ...

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced an amendment to ...